InfaCare Pharmaceutical

InfaCare Pharmaceutical Corporation is a specialty pharmaceutical company dedicated to developing and commercializing drugs for neonatal and pediatric patient populations. Its neonatal product, Stanate, is being developed as a treatment for infant jaundice or hyperbilirubinemia. The company was founded in 2005 and is headquartered in Pennsylvania.